Mequinol is a topical skin-lightening (depigmenting) agent that a pharmacy may compound when a prescriber orders it.
Mequinol, also called 4-methoxyphenol, is a phenol applied to the skin to lighten dark spots. Its mechanism is not fully understood. DrugBank describes it as a substrate of tyrosinase, the enzyme that starts melanin production, that may competitively inhibit the formation of melanin precursors, and as a chemical that forms compounds toxic to pigment cells when it is oxidized inside them. The only FDA-approved product, Solage (mequinol and tretinoin) topical solution, was approved for solar lentigines, the flat brown spots caused by long-term sun exposure, used along with skin care and sun avoidance. Its label does not cover melasma or postinflammatory hyperpigmentation. Drugs@FDA lists Solage as discontinued, and DailyMed currently lists no mequinol product. A prescriber might order mequinol compounded in a topical vehicle or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
The Solage label carries no boxed warning and lists no contraindications. It warns that the solution irritates skin, commonly causing redness, burning, stinging, peeling and itching, and that it can cause phototoxicity, so treated skin should be kept out of sunlight and away from sunlamps. It can cause hypopigmentation (lightening of the skin), and the label urges caution in people with a personal or family history of vitiligo. The label says not to use it with drugs known to make skin sun-sensitive, such as thiazides, tetracyclines, fluoroquinolones, phenothiazines and sulfonamides. It also says pregnant women should avoid Solage because of embryofetal toxicity, and that breastfeeding women should not apply it to the nipple and areola; LactMed has no mequinol record. The solution is flammable. If irritation becomes severe or spots darken, talk to your prescriber or pharmacist.
Mequinol (4-methoxyphenol) is a melanocytotoxic phenol and tyrosinase substrate. DrugBank describes formation of toxic quinones when it is oxidized in melanocytes and suggests tretinoin may add to this by lowering intracellular glutathione, while the Solage label states that the mechanism in solar lentigines is unknown. After topical application of Solage, mequinol reached peak plasma concentration at about 2 hours, and tretinoin absorption did not raise systemic levels above endogenous concentrations. Solage (NDA 020922, approved 1999, last held by Almirall and now discontinued) was indicated for solar lentigines as an adjunct to sun avoidance; melasma and postinflammatory hyperpigmentation are not FDA-approved indications. The Solage label attributes the malformations seen in rabbits to tretinoin and reports no treatment-attributed effects in rabbits given topical mequinol alone. A 2025 systematic review of solar lentigine trials included mequinol with tretinoin among the topical treatments studied. Avoid concurrent photosensitizers, counsel on strict photoprotection, and monitor for local irritation and hypopigmentation; Cleveland Clinic notes improvement is gradual and spots may darken again after stopping. Dosing is per prescriber. Mequinol is not a controlled substance.
Compounded at Bayview
Patient guides for the preparations we make most often. Each one is compounded to order and requires a prescription.
We do not have a patient page for this ingredient yet. That does not mean we cannot make it. Bayview compounds this ingredient to a prescriber's order, and our full compounding formulary lists every preparation we make. Viewing the formulary requires a prescriber account.
Prescriber sign inFor prescribers
Every preparation in our formulary that contains this ingredient. Strength, base and dose form are set by the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.